# A Study of Brenipatide in Adult Participants With Major Depressive Disorder

> **NCT07412756** · PHASE3 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 1000 (estimated)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Brenipatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07412756
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412756, "A Study of Brenipatide in Adult Participants With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07412756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*